Información del producto
Nombre:
Moveltipril calcium
Sinónimos:
- <span class="text-smallcaps">L</smallcap>-Proline, N-(cyclohexylcarbonyl)-<smallcap>D</span>-alanyl-(2S)-3-mercapto-2-methylpropanoyl-, calcium salt (2:1)
- <span class="text-smallcaps">L</span>-Proline, 1-[(2S)-3-[[(2R)-2-[(cyclohexylcarbonyl)amino]-1-oxopropyl]thio]-2-methyl-1-oxopropyl]-, calcium salt (2:1)
- <span class="text-smallcaps">L</span>-Proline, 1-[3-[[2-[(cyclohexylcarbonyl)amino]-1-oxopropyl]thio]-2-methyl-1-oxopropyl]-, calcium salt (2:1), [R-(R*,S*)]-
- Altiopril calcium
- Calcium (2R)-1-[(2R)-3-[2-(cyclohexanecarbonylamino)propanoylsulfanyl]-2-methylpropanoyl]pyrrolidine-2-carboxylate
- Lowpres
- Mc 838
Descripción:
Moveltipril calcium is a calcium salt of the pressor moveltipril. It is used to treat inflammatory bowel disease and high blood pressure. Moveltipril calcium is a prodrug that is hydrolyzed in vivo to moveltipril, its active form. Moveltipril increases the blood pressure by blocking the production of angiotensin II and has been shown to have beneficial effects on insulin resistance in patients with type 2 diabetes mellitus. The pharmacokinetic properties of moveltipril calcium are linear, with a terminal half-life of about 18 hours. This drug can be administered orally and has few adverse effects.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
835.1 g/mol
Fórmula:
C38H58CaN4O10S2
Pureza:
Min. 95%
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
